Check out your Company Bowl for anonymous work chats.
Absci and AMD to Accelerate Breakthroughs in AI Drug Discovery $20 Million Equity Investment from AMD Strengthens Absci’s Leadership in AI Drug Discovery and Further Expands Biopharma Adoption of AMD Instinct Accelerators and ROCm Software
Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases
We are so very proud to be one of the Fortune 50 AI Innovators.
AbSci named Oregon Entrepreneurs Network 'Startup of the Year!' "AbSci was chosen because its leadership has demonstrated tremendous tenacity over the years, making real progress toward becoming a substantial employer and contributor to the biotech sector in Oregon. The company’s value proposition is extraordinary, and its team is remarkably cohesive, with breakthroughs to their product evolution coming from scientists working at many levels across their production process."
